In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Before we dive into what’s new with wrapper classes in Java 21, let’s do a quick review. Wrapper behavior was also refined as groundwork for Project Valhalla’s value types. Wrapper classes in Java 21 ...

Generic drugmakers accused of price-fixing schemes Judge says direct buyers met class certification requirements A federal judge certified several classes of direct and end-payer purchasers for test ...

Abstract: Recent years have witnessed renewed interest in multi-class traffic models, inspired in no small part by the impending arrival of Connected and Autonomous Vehicles, whose behaviour is likely ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country. Subscribe to read ...

Nov 4 (Reuters) - Walgreens (WBA.O), opens new tab has agreed to pay $100 million to settle a proposed class action lawsuit accusing it of fraudulently overcharging customers for a decade when they ...

Sept 4 (Reuters) - Walgreens is facing a proposed class action lawsuit brought on Wednesday by customers who say they weren’t warned that the pharmacy chain’s generic version of cold medicine Mucinex ...